Euromit meeting

Euromit meeting

Euromit meeting that will be held in the beautiful city of Angers, France, at the Convention Center, from May 30 to June 4, 2026.

Euromit is the largest international conference on mitochondrial diseases in Europe. With over 850 researchers, physicians, and patient advocates expected, join us for:

  • Cutting-edge science
  • World-class speakers
  • Networking opportunities

Early bird registrations are open: REGISTER HERE

Stay up to date – visit the website: www.euromit2026.eu

2025 Key Dates

  • October 1: Abstract submission

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Postdoctoral Position in Paris

WG4 METAHEART CA Webinar

From Omics to Mechanisms: Mechano-Energetic Uncoupling in Heart Failure

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

Guido Kroemer’s team in Paris is seeking to recruit outstanding postdoctoral fellows with strong expertise in molecular and cellular biology, immunology, and/or physiology to investigate the role of ACBP/DBI, a...
May 19th, 13.00 London Time, 14.00 Berlin Time Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) & Dr Edoardo Bertero (Italy) WG4 Deputy Leads
Wednesday 22nd April, 12.00 GMTJoin us on Zoom – click here to register. Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) &Dr Edoardo Bertero (Italy) WG4 Deputy...
📆 Deadline: Submission for applications is open until May 1, 2026. 🤝 Work together, exchange technology & build new scientific collaborations within EU-METAHEART COST Action. ➡️ STSMs are THE way to...
Save-the-Date AMPK 2026
📍 Lunteren, Netherlands📅 27–29 September 2026This 3-day meeting will bring together leading experts and early-career researchers to discuss the latest advances in AMPK signaling, nutrient sensing pathways, and their roles...
👏 Congratulations to our EU-METAHEART COST Action WG4 leader Dunja Aksentijevic Ricciarelli for the publication of her new study in Nature Cardiovascular Research: https://lnkd.in/db3WWu_Q💡 “Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2...